Page 1 of 28, showing 20 records out of 542 total, starting on record 1, ending on 20
| Event |
Where |
When |
|
|
13th World Congress of Gynecological Endocrinology, “Aromatase as key regulator of intracrinology”, Florence, February 2008 |
|
2008 |
|
|
Tokyo expert meeting. “Combined androgen blockade should be the only hormone therapy used in prostate cancer”. Tokyo, April 2008 |
|
2008 |
|
|
96th Annual Meeting of the Japan Urological Association, “Dream of antiandrogens therapy for prostate cancer”, Yokohama, April 2008 |
|
2008 |
|
|
Workshop on Pre-receptor steroid metabolism as target for pharmacological treatment –“Intracrinology, pre-receptor control of intracellular active steroid concentration,”, Munich, May 2008 |
|
2008 |
|
|
The Endocrine Society’s 90th Annual Meeting, “Clinical aspects of Aromatase Inhibitor Resistance”, San Francisco, June 2008 |
|
2008 |
|
|
13 International Congress on Hormonal Steroids and Hormones & Cancer, “ Prostate Cancer”, Quebec, September 2008 |
|
2008 |
|
|
Multidisciplinary International Conference, “Androgens and breast cancer”, Pisa, October 2008 |
|
2008 |
|
|
18th International symposium of the Journal of Steroid Biochemistry and Molecular Biology, “Intracrinology at the basis of tissue-specific hormone replacement therapy”, Seefeld, Tyrol, sept 2008 |
|
2008 |
|
|
Symposia, State of the ART speaker, International Society for the study of Women’s Sexual Health (ISSWS), “The major role of extragonadal sex steroid formation in women, especially after menopause”, O |
|
2007 |
|
|
The Breast, First International Congress on Breast Development, Functions and Diseases, Turin, Lingotto Convention Center, September 27-30, 2007 |
|
2007 |
|
|
21st World congress of Dermatology, “Sophisticated steroid-making machinery of the skin”, Buenos aires, October 2007 |
|
2007 |
|
|
The King Faisal Memorial Lecture series in medicine (2007), “The remarkable success of hormone therapy of prostate cancer in 2007, King ABD Al-Aziz City for Science and Technology, Auditorium Riyadh, |
|
2007 |
|
|
CBI Conference on Menopause Pharmacotherapeutic Development “Tissue-specific HRT combining prevention of breast cancer”, Philadelphia, January 2006 |
|
2006 |
|
|
International Society of Gynecological Endocrinology Symposium on “The role of androgens in female sexual function” – “Current knowledge of androgens in breast cancer”, Florence, March 2006. |
|
2006 |
|
|
Menopause Conference, Center for Business Intelligence, Menopause Pharmacotherapeutic Development – Current Trends, Challenges and Scientific Advances for Drug Development for Menopause and Related Is |
|
2006 |
|
|
Les Nouvelles Approches au Bien Vieillir des Femmes – Symposium Canada-France “Femmes et veillessement – rôle des hormones », Nice, March 2006. |
|
2006 |
|
|
Biomedex 2006 – Success in technology transfer: the first 18 months – Proof of concept, Montreal, May 2006. |
|
2006 |
|
|
Androgen Excess Society – 4th Annual Meeting “Role of the adrenal in androgen excess in women”, Boston, June 2006. |
|
2006 |
|
|
2006 Prostate Cancer Update at the occasion of Dacapeptyl’s 20th Anniversary, “The multiple intracrine targets in the prostate: opportunities and challenges”, Budapest, September 2006 |
|
2006 |
|
|
Gunma University Urological meeting, “The key role of combined androgen blockade in prostate cancer”, Tagasaki, October 2006 |
|
2006 |
|